The Potential Role of Buprenorphine in the Treatment of Opioid Dependence in HIV-Infected Individuals and in HIV Infection Prevention

Altice, Frederick L.; Sullivan, Lynn E.; Smith-Rohrberg, Duncan; Basu, Sanjay; Stancliff, Sharon; Eldred, Lois
December 2006
Clinical Infectious Diseases;12/15/2006 Supplement, Vol. 43, pS178
Academic Journal
Untreated opioid dependence is a major obstacle to the successful treatment and prevention of human immunodeficiency virus (HIV) infection. In this review, we examine the interwoven epidemics of HIV infection and opioid dependence and the emerging role of buprenorphine in improving HIV treatment outcomes among infected individuals, as well as its role in primary and secondary prevention. This article addresses some of the emerging issues about integrating buprenorphine treatment into HIV clinical care settings and the various strategies that must be considered. Specifically, it addresses the role of buprenorphine in improving HIV treatment outcomes through engagement in care, access to antiretroviral therapy and preventive therapies for opportunistic infections, and the potential benefits of and pitfalls in integrating buprenorphine into HIV clinical care settings. We discuss the key research questions regarding buprenorphine in the area of improving HIV treatment outcomes and prevention, including a review of published studies of buprenorphine and antiretroviral treatment and currently ongoing studies, and provide insight into and models for integrating buprenorphine into HIV clinical care settings. Dialogue among practitioners and policy makers in the HIV care and substance abuse communities will facilitate an effective expansion of buprenorphine and ensure that these beneficial outcomes are achieved.


Related Articles

  • A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Sullivan, Lynn E.; Barry, Declan; Moore, Brent A.; Chawarski, Marek C.; Tetrault, Jeanette M.; Pantalon, Michael V.; O'Connor, Patrick G.; Schottenfeld, Richard S.; Fiellin, David A. // Clinical Infectious Diseases;12/15/2006 Supplement, Vol. 43, pS184 

    Background. Untreated opioid dependence adversely affects the care of human immunodeficiency virus (HIV)-positive patients. Buprenorphine, a partial opioid agonist, is available for maintenance treatment of opioid dependence in HIV specialty settings. We investigated the feasibility and efficacy...

  • Enfuvirtide Added to an Optimized Antiretroviral Regimen Provided Significant Benefits in Patients with Multidrug-Resistant HIV Infection. Lorber, Bennett // Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p877 

    The article presents information on papers related to infectious diseases in the U.S. The paper "Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America," by J.P. Lalezari, K. Henry, M. O'Hearn et al. studied that enfuvirtide added to an optimized...

  • Retention in Opioid Substitution Treatment: A Major Predictor of Long-Term Virological Success for HIV-Infected Injection Drug Users Receiving Antiretroviral Treatment. Roux, Perrine; Carrieri, M. Patrizia; Cohen, Julien; Ravaux, Isabelle; Poizot-Martin, Isabelle; Dellamonica, Pierre; Spire, Bruno // Clinical Infectious Diseases;11/1/2009, Vol. 49 Issue 9, p1433 

    Background. The positive impact of opioid substitution treatment (OST) on opioid-dependent individuals with human immunodeficiency virus (HIV) infection is well documented, especially with regard to adherence to highly active antiretroviral therapy (HAART). We used the data from a 5-year...

  • Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians. Cunningham, Chinazo O.; Kunins, Hillary V.; Roose, Robert J.; Elam, Rashiah T.; Sohier, Nancy L.; Sohler, Nancy L // JGIM: Journal of General Internal Medicine;Sep2007, Vol. 22 Issue 9, p1325 

    Background: Illicit drug use is common among HIV-infected individuals. Buprenorphine enables physicians to simultaneously treat HIV and opioid dependence, offering opportunities to improve health outcomes. Despite this, few physicians prescribe buprenorphine.Objective:...

  • Corroborative Study Confirmed That Adding Enfuvirtide to an Optimized Antiretroviral Regimen Benefited Patients with Multidrug-Resistant HIV Infection. Lorber, Bennett // Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p878 

    The article presents information on papers related to infectious diseases in Europe and Australia. The paper "Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia," by A. Lazzarin, B. Clotet, D. Cooper, et al. confirmed that adding enfuvirtide to an...

  • Declining Incidence of AIDS and Increasing Prevalence of AIDS Presenters Among AIDS Patients in Italy. Castelnuovo, B.; Chiesa, E.; Rusconi, S.; Adorni, F.; Bongiovanni, M.; Melzi, S.; Cicconi, P.; Tordato, F.; Meroni, L.; Bini, T.; d'Arminio Monforte, A. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2003, Vol. 22 Issue 11, p663 

    Presented here are the results of a cohort study conducted on 3,483 consecutive HIV/AIDS patients between January 1993 and December 2000 to determine trends in AIDS incidence and presentation. The incidence of AIDS was calculated in the general population and examined further according to...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Jan2005, Vol. 19 Issue 1, p58 

    The article focuses on antiviral agents for AIDS and sexually transmitted diseases. Researchers at Harvard Medical School have observed limited durability of viral control following treatment of patients with acute HIV infection. Good treatment response was also achieved for ritonavir-boosted...

  • Patient factors to target for elimination of mother-to-child transmission of HIV. Mnyani, Coceka N.; Simango, Adonia; Murphy, Joshua; Chersich, Matthew; McIntyre, James A. // Globalization & Health;2014, Vol. 10 Issue 1, p1 

    Background There is great impetus to achieve elimination of mother-to-child transmission of HIV (eMTCT) by 2015, and part of this is to identify factors to target to achieve the goal. This study thus identified key patient factors for MTCT in a high HIV prevalence setting in Johannesburg, South...

  • ANTIRETROVIRAL PROTEIN BINDING IN BLOOD AND SEMINAL PLASMAS. Velazquez, Norieliz De Jesus; Tirado, Grissell; Hill, Martin D. // Ethnicity & Disease;Spring2008 Supplement1, Vol. 18, pS1:65 

    The most frequent method of human immunodeficiency virus (HIV) transmission is sex with an infected partner. We conducted two studies to determine the active concentration of antiretroviral drugs needed to help improve viral suppression. One study measured free drug levels in blood and seminal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics